Last reviewed · How we verify
NCT05060133
Changes of the Upper Airway Volume After Orthognathic Surgery
trial testing Orthognathic Surgery in OSA in 62 participants. Completed in 28 December 2022.
31 August 2022
Quick facts
| Lead sponsor | Lund University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 62 |
| Start date | 15 May 2021 |
| Primary completion | 31 August 2022 |
| Estimated completion | 28 December 2022 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Orthognathic Surgery
Conditions studied
- OSA — all drugs for OSA →
- Malocclusion — all drugs for Malocclusion →
- Dentofacial Deformities — all drugs for Dentofacial Deformities →
Sponsor
Lund University Hospital
Who can join
Adults 18 to 30, any sex, with OSA or Malocclusion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the present project is to analyze the impact from orthognathic surgery on the upper airway respiratory volume. The primary objective is comparison of differences in the in the airway changes due to maxillary movements and mandibular movements. Secondary objectives are the analysis of any correlation between the magnitude of the movement and the airway volume, correlation between the direction of the movements and the changes in airway volume and correlation with Health-Related Quality of Life (HRQoL). Expected confounding factors like smoking habits and Body Mass Index (BMI) will be analyzed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05060133
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Orthognathic Surgery
Trials testing the same drug.
- NCT05536596 — Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy · Phase 2, PHASE3 · unknown
- NCT04823325 — Determining the Presence of RAP in Orthognathic Patients and Its Effect on Root Resorption by Biomarkers · completed
- NCT02789787 — Clinical Effectiveness of Late Maxillary Protraction for Cleft Lip and Palate · completed
Other recruiting trials for OSA
Currently open trials in the same condition.
- NCT06910930 — Impact of Muscle Training Device on Non-Severe OSA · NA · recruiting
- NCT07060079 — The Use of Entropy to Assess Sleep Disordered Breathing in Chronic Respiratory Disease · recruiting
- NCT06110962 — Detecting Heart Rate, Respiration, and Sleep With the Sleeptracker-AI Under-mattress Monitor · recruiting
- NCT06591169 — Lifestyle Changes in PCOS with OSA and NAFLD · NA · recruiting
- NCT06091098 — Reversible Effect of Falling Ventilatory Drive in Drive-dependent OSA · NA · recruiting
Other Lund University Hospital trials
Trials by the same sponsor.
- NCT07373184 — Virtual Planning of Total Temporomandibular Joint Replacement · recruiting
- NCT02958852 — A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on M · Phase 2 · completed
- NCT06389799 — A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI) · Phase 2 · recruiting
- NCT06248996 — a Multicentre Phase III Study of Risk-based Treatment Intensification With Hyperfractionated Radiotherapy in Head and Ne · Phase 3 · recruiting
- NCT06840639 — The Impact of Dental Health on Complications During and Following Radiotherapy in the Head and Neck Region. · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05060133 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lund University Hospital
- Last refreshed: 30 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05060133.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing